Connor, Clark & Lunn Investment Management (CC&L)
CRBU icon

Connor, Clark & Lunn Investment Management (CC&L)’s Caribou Biosciences CRBU Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.4K Buy
+30,741
New +$52.8K ﹤0.01% 1516
2023
Q3 		– Sell
-162,221
Closed -$689K – 1397
2023
Q2 		$689K Buy
162,221
+83,071
+105% +$373K ﹤0.01% 903
2023
Q1 		$420K Buy
79,150
+34,789
+78% +$217K ﹤0.01% 930
2022
Q4 		$279K Buy
+44,361
New +$395K ﹤0.01% 989

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CRBU Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 30,741 shares worth $58.4K. The stake represents ﹤0.01% of the portfolio and ranks #1516 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in CRBU as recently as Q2 2023.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CRBU in Q4 2022 and has held it in 4 quarters since. The position peaked at $689K in Q2 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 30,741 shares of Caribou Biosciences worth $58.4K as of Q1 2026.
  • Caribou Biosciences was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1516 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Caribou Biosciences in Q4 2022 and has held it in 4 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Caribou Biosciences position peaked at $689K in Q2 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.